View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Roger McIntyre, MD, FRCPC, and Joseph Goldberg, MD, discuss tardive dyskinesia (TD), mood disorders, and antipsychotics. They review current clinical considerations and assessments, including whether antipsychotic prescriptions for mood disorders have increased, if patients with mood disorder are at higher risk for TD and why, and when and how to use an AIMS exam, even in telepsychiatry. They also review the evidence base for VMAT2 inhibitors in TD, what nonevidence-based treatments healthcare professionals should avoid, and how to choose between the 2 VMAT2 inhibitors.
Presenters:
Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology
Department of Psychiatry/Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
Department of Psychiatry
Toronto, Canada
Joseph Goldberg, MD
Clinical Professor of Psychiatry
Department of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Slides from a presentation that educates clinicians on Huntington disease and the management of chorea
Victor W. Sung, MD
Released: September 17, 2021
Slides from a presentation that educates clinicians on strategies to improve mood disorders and tardive dyskinesia (TD) treatment.
Greg Mattingly, MD
Released: September 1, 2021
In Neuroscience Research Review (GME Research Review), Drs Gupta and McEvoy respond to current articles on tardive dyskinesia (TD) including pharmacologic treatments and identification via the AIMS exam
Sanjay Gupta, MD
Joseph P. McEvoy, MD
Physicians:
maximum of 0.75 AMA PRA Category 1 Credits™
Registered Nurses:
0.75 Nursing contact hours
Pharmacists:
0.75 contact hours (0.075 CEUs)
Physician Assistants:
maximum of 0.75 hours of AAPA Category I CME credits
Released: August 31, 2021
Expired:
August 30, 2022
In Neuroscience Research Review (GME Research Review), Drs Gupta and McEvoy respond to current articles on tardive dyskinesia (TD) including pharmacologic treatments and identification via the AIMS exam
Sanjay Gupta, MD
Joseph P. McEvoy, MD
Physicians:
maximum of 0.75 AMA PRA Category 1 Credits™
Registered Nurses:
0.75 Nursing contact hours
Pharmacists:
0.75 contact hours (0.075 CEUs)
Physician Assistants:
maximum of 0.75 hours of AAPA Category I CME credits
Released: August 31, 2021
Expired:
August 30, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.